Who we're up against
Why we win
Deal killers and landmines
Market Myths
100

This QMS competitor positions itself as a developer-first quality solution and often resonates most with highly technical software teams.

Ketryx

100

What's the number one reason buyers choose Ultralight post-acquisition?

Brand trust, reputation, medtech expertise

100

Deals often stall when this team isn’t involved early in the evaluation - especially when they believe we’ll slow down Jira workflows or duplicate their dev stack.

Product/engineering

100

Some people tool people are concerned that this tool will take the place of experts in medical fields, including the job of managing a Quality System

AI

200

We’re seeing fewer competitive encounters with this QMS vendor that was previously a major focus in our GTM strategy.

Qualio

200

This full system feature is often touted as a reason GG QMS customers stay.

Traceability & workspace linkages

200

This is the #1 objection we hear from early-stage companies on DIY solutions when evaluating an eQMS.

Not ready yet / No need

200

This is still not a requirement for registering with the FDA, despite upcoming alignment?

ISO 13485

300

This clinical competitor has inbuilt training for research sites to use, in the same platform as running the trial.

Veeva Clinical or Castor

300

This GG product is so flexible and easy to use, many customers can get started using it from the Academy alone

Clinical

300

When we don’t proactively position our holistic solution, including our medtech expert-led onboarding and support, prospects assume we’re just another software tool and go with this type of alternative.

generic eQMS

300

This type of medical device typically requires a clinical trial to demonstrate safety and effectiveness before clearance or approval.

Class III (high risk)